ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas"
Episode Synopsis
In February, a team of scientists achieved a long-held scientific goal — creating a bespoke CRISPR editing therapy to treat a single patient with a unique genetic mutation. “Baby KJ” got his own custom treatment only six months after he was born. Now, Rebecca Ahrens-Nicklas, a pediatrician and gene therapy scientist at CHOP, and Kiran Musunuru, a UPenn gene editing scientist, have a plan to replicate that success. They’re joining Post-Hoc Live to talk about what’s next.
More episodes of the podcast Post-Hoc Live
The fight over Metsera
03/11/2025
Breaking down the XBI — with Josh Schimmer
10/09/2025
Choosing the Endpoints 11
03/09/2025
In God we trust